Introduction
Until 12 th week of gestation the foetus is entirely dependent on maternal thyroxine. Inadequate thyroxine replacement may lead to a substantially lower IQ of the offspring and also an increased miscarriage rate.
In the first trimester TSH is not an optimal monitoring marker of thyroid status as it is supressed by the rising HCG level. According to established clinical guidelines, in order to protect the foetus, FT4 should be maintained close to the upper limit of normal and TSH should be less than 2.5 mIU/L in the first trimester by appropriately adjusting the dose of levothyroxine by 8 weeks gestation.
We conducted an audit of pregnant hypothyroid females to answer the question "Has management of thyroid status met current standards?" and, if not, to decide how management should be improved.
Method

68
hypothyroid pregnant patients presenting in 2012 to Mid-Yorkshire Trust, UK, were identified using the Euroking database and hospital records. These formed the basis of the audit. Information extracted included gestation week when TFTs were taken, time to specialist referral and the appropriateness and the timing of any action taken with respect to the TFTs. Only just over a quarter (27%) were seen by specialist by 8/40 gestation in time to implement effective change
Results
Discussion
Only half the patients (49%) had TFTs taken by 8 weeks gestation and only a quarter (27%) where seen by the specialist in time to make effective change to levothyroxine dose if required. Two thirds saw the specialist within two weeks of referral. Of 33/68 checked by 8/40 18 patients required no dosage change and in 9 it was appropriately increased. However, in 6 patients who should have had a levothyroxine dose increase no change was made. Moreover review of results from 23/68 first tested after 12 weeks gestation suggested it was likely that 10 (43%) should have had a dose increase in the first trimester and that the foetus may have been put at risk.
Conclusion
Currently accepted standards for monitoring and management of hypothyroidism in pregnancy were achieved in only 40% (27/68) of patients. Education of primary care physicians, midwives and patients is required so that they are aware of the need to undertake and act upon TFTs early in pregnancy or even before when conception is being contemplated. This will help to ensure a better outcome for both mother and baby.
The audit needs repeating in a year to see if the situation has improved.
